Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

PHASE2CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Healthy

Interventions

BIOLOGICAL

DTP/HB/Hib vaccine

Dosage equal to 0.5 mL administered intramuscularly

BIOLOGICAL

DTP/HB and Hib vaccine

Dosage equal to 0.5 mL administered intramuscularly

Trial Locations (3)

Garuda Primary Health Center, Bandung

Ibrahim Adji Primary Health Care Center, Bandung

Puter Primary Health Center, Bandung